NO20065624L - Fremgangsmater for a predikere terapeutisk respons av midler som virker pa veksthormonreseptor - Google Patents

Fremgangsmater for a predikere terapeutisk respons av midler som virker pa veksthormonreseptor

Info

Publication number
NO20065624L
NO20065624L NO20065624A NO20065624A NO20065624L NO 20065624 L NO20065624 L NO 20065624L NO 20065624 A NO20065624 A NO 20065624A NO 20065624 A NO20065624 A NO 20065624A NO 20065624 L NO20065624 L NO 20065624L
Authority
NO
Norway
Prior art keywords
methods
growth hormone
hormone receptor
therapeutic response
agents acting
Prior art date
Application number
NO20065624A
Other languages
English (en)
Inventor
Luis A Parodi
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of NO20065624L publication Critical patent/NO20065624L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

Det beskrives framgangsmåter for å predikere størrelsen på et individs terapeutiske respons til midler som virker på veksthormonreseptoren. Foretrukne aspekter inkluderer metoder for å øke høyden til mennesker som er av kort vekst, og for å behandle obesitet og akromegali.
NO20065624A 2004-07-08 2006-12-06 Fremgangsmater for a predikere terapeutisk respons av midler som virker pa veksthormonreseptor NO20065624L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58638004P 2004-07-08 2004-07-08
PCT/IB2005/002086 WO2006006072A1 (en) 2004-07-08 2005-06-27 Methods for predicting therapeutic response to agents acting on the growth hormone receptor

Publications (1)

Publication Number Publication Date
NO20065624L true NO20065624L (no) 2007-01-03

Family

ID=34972546

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065624A NO20065624L (no) 2004-07-08 2006-12-06 Fremgangsmater for a predikere terapeutisk respons av midler som virker pa veksthormonreseptor

Country Status (15)

Country Link
US (1) US20080070248A1 (no)
EP (1) EP1766067A1 (no)
JP (1) JP2008505634A (no)
KR (1) KR20070029245A (no)
CN (1) CN1981056A (no)
AU (1) AU2005261356A1 (no)
BR (1) BRPI0512709A (no)
CA (1) CA2572675A1 (no)
IL (1) IL180098A0 (no)
MX (1) MXPA06014924A (no)
NO (1) NO20065624L (no)
RU (1) RU2006145829A (no)
TW (1) TW200617176A (no)
WO (1) WO2006006072A1 (no)
ZA (1) ZA200700045B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5137096B2 (ja) * 2006-07-05 2013-02-06 独立行政法人酒類総合研究所 特定の麹菌の同定方法
WO2010060935A1 (en) * 2008-11-26 2010-06-03 Merck Serono S.A. Compositions and methods for treating growth hormone deficiency
WO2010135391A2 (en) * 2009-05-21 2010-11-25 Svetlana Ten An improved method for diagnosing or predicting short stature in humans
WO2012104838A1 (en) * 2011-02-01 2012-08-09 Mor Researchr Applications Ltd. Use of hgh for the treatment of small for gestational age infants under two years of age

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0300959D0 (sv) * 2002-12-19 2003-04-02 Pharmacia Ab Methods for predicting therapeutic response to agents acting on the growth hormone receptor

Also Published As

Publication number Publication date
ZA200700045B (en) 2008-06-25
RU2006145829A (ru) 2008-08-20
AU2005261356A1 (en) 2006-01-19
MXPA06014924A (es) 2007-02-28
BRPI0512709A (pt) 2008-04-01
IL180098A0 (en) 2007-05-15
JP2008505634A (ja) 2008-02-28
EP1766067A1 (en) 2007-03-28
KR20070029245A (ko) 2007-03-13
WO2006006072A1 (en) 2006-01-19
US20080070248A1 (en) 2008-03-20
CA2572675A1 (en) 2006-01-19
CN1981056A (zh) 2007-06-13
TW200617176A (en) 2006-06-01

Similar Documents

Publication Publication Date Title
DE69929235D1 (de) Spiro-indole als y5-rezeptor antagonisten
Berger et al. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine
WO2001087335A3 (en) Method for selectively inhibiting ghrelin action
ATE411021T1 (de) Überbrückte piperidinderivate als melanocortin- rezeptor-agonisten
ITMI20042132A1 (it) Dispositivo e metodo per la terapia dell'obesita'
AU2003294290A8 (en) Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
NO20053490D0 (no) Methods for prediciting therapeutic response to agents acting on the growth hormone receptor
NO20072518L (no) Kjonns stereoid forloper alene eller i kombinasjon med en selektiv ostrogen reseptor modulator og /eller med ostrogener og /eller en type 5 CGMP fosfodiesteraseinhibitor for a forebygge eller behandle vaginal torrhet og seksuell dysfunksjon hos postmenopausale kvinner.
ATE323088T1 (de) Bicyclische pyridin-und pyrimidinderivate als neuropeptid y rezeptorantagonisten
NO20055516L (no) Kannabinoidreceptorligander og anvendelser derav
NO20065624L (no) Fremgangsmater for a predikere terapeutisk respons av midler som virker pa veksthormonreseptor
DE60317677D1 (de) Ox40 (=cd134) rezeptor agonisten und therapeutische verwendung
EP1333650A3 (en) Method of enabling user access to services
DE602004028228D1 (de) Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
NO20050140L (no) UE assistert systemdatabaseoppdatering
NO20063636L (no) Muskariniske acetylkolinrecptoorantagonister
DK1482925T3 (da) 5- (2-hydroxy-3 -'1 - (3-trifluormethylphenyl) cyclopropylpropionylamino) phtalid og relaterede forbindelser med progesteronreceptormoducerende aktivitet til anvendelse i fertilitetskontrol og hormonerstatningsterapi
WO2005030187A3 (en) Iloprost in combination therapies for the treatment of pulmonary arterial hypertension
WO2004044738A3 (en) Techniques for supporting application-specific access controls with a separate server
WO2004084943A8 (en) Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation
NO20055187L (no) Fremgangsmate for behandling og forebygging av lavere urinkanal symptomer
DK1800134T3 (da) Fremgangsmåde til diagnosticering og behandling af Chron's sygdom
WO2007070357A3 (en) Secure wireless network
NO20051663L (no) Fremgangsmater for behandling av neurodegenerasjon
WO2004110385A3 (en) Modulators of the glucocorticoid receptor and method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application